会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • PIPERIDINE DERIVATIVES
    • 哌啶衍生物
    • WO2011101304A2
    • 2011-08-25
    • PCT/EP2011/052101
    • 2011-02-14
    • F. HOFFMANN-LA ROCHE AGBAUMANN, KarlheinzFLOHR, AlexanderGOETSCHI, ErwinGREEN, LukeJOLIDON, SyneseKNUST, HennerLIMBERG, AnjaLUEBBERS, ThomasTHOMAS, Andrew
    • BAUMANN, KarlheinzFLOHR, AlexanderGOETSCHI, ErwinGREEN, LukeJOLIDON, SyneseKNUST, HennerLIMBERG, AnjaLUEBBERS, ThomasTHOMAS, Andrew
    • C07D401/14C07D413/14C07D417/14C07D471/04C07D487/04C07D498/04A61K31/4523A61P25/28
    • C07D471/04C07D401/14C07D413/14C07D417/14C07D487/04C07D498/04
    • The invention relates to compounds of formula (I). Hetaryl I is a five or six membered heteroaryl group, containing 1 to 3 heteroatoms, selected from O, S or N; hetaryl II is a five or six membered heteroaryl group, containing 1 to 3 heteroatoms, selected from O, S or N, or is a two membered ring system containing 1 to 4 heteroatoms selected from S, O or N, wherein at least one ring is aromatic in nature; R 1 is lower alkyl, lower alkoxy, lower alkyl substituted by halogen, or halogen; R 2 is halogen, lower alkyl, lower alkoxy, hydroxy, lower alkyl substituted by halogen, lower alkyl substituted by hydroxy or benzo[1,3]dioxolyl, or is -(CHR) p -phenyl, optionally substituted by halogen, lower alkyl, lower alkoxy, S(O) 2 -lower alkyl, cyano, nitro, lower alkoxy substituted by halogen, dimethylamino, -(CH 2 )P-NHC(O)O-Iower alkyl, or lower alkyl substituted by halogen, and R is hydrogen, halogen, hydroxy or lower alkoxy, or is cycloalkenyl or cycloalkyl, optionally substituted by hydroxy or lower alkyl substituted by halogen, or is a five or six membered heteroaryl group, containing 1 to 3 heteroatoms, selected from O, S or N, which is optionally substituted by halogen, lower alkyl, lower alkoxy or dimethylamino, or is O-phenyl, optionally substituted by halogen, or is heterocycloalkyl, optionally substituted by halogen, hydroxy, lower alkyl substituted by halogen or C(O)O-lower alkyl; R 3 is hydrogen, lower alkyl, cyano or phenyl; R 4 is lower alkoxy, lower alkyl or halogen; p is 0 or 1; n is 0, 1 or 2; if n is 2 then R 4 may be the same or different; m is 0, 1 or 2; if m is 2 then R 1 may be the same or different; o is 0, 1, 2 or 3, if o is 2 or 3 then R 2 may be the same or different; or to pharmaceutically active acid addition salts thereof. The compounds of formula (I) are modulators for amyloid beta and thus, they may be useful for the treatment or prevention of a disease associated with the deposition of β-amyloid in the brain, in particular Alzheimer's disease, and other diseases such as cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct dementia, dementia pugilistica and Down syndrome.
    • 本发明涉及式(I)的化合物。 Hetary11是含有1至3个选自O,S或N的杂原子的五元或六元杂芳基; 杂芳基II是含有1至3个选自O,S或N的杂原子的五元或六元杂芳基,或者是含有1至4个选自S,O或N的杂原子的二元环体系,其中至少一个环 本质上是芳香的; R 1为低级烷基,低级烷氧基,被卤素取代的低级烷基或卤素; R 2是卤素,低级烷基,低级烷氧基,羟基,被卤素取代的低级烷基,被羟基或苯并[1,3]二氧杂环戊烯基取代的低级烷基,或者是 - (CHR)p 低级烷基,低级烷氧基,S(O)2 - 低级烷基,氰基,硝基,被卤素取代的低级烷氧基,二甲基氨基, - (CH 2) (O)O-低级烷基或被卤素取代的低级烷基,且R为氢,卤素,羟基或低级烷氧基,或者为环烯基或环烷基,任选被羟基或低级 被卤素取代的烷基,或者是含有1至3个选自O,S或N的杂原子的五元或六元杂芳基,其任选被卤素,低级烷基,低级烷氧基或二甲基氨基取代,或者是O-苯基, 任选被卤素取代,或者为任选被卤素,羟基,被卤素取代的低级烷基或C(O)O-低级烷基取代的杂环烷基; R 3是氢,低级烷基,氰基或苯基; R 4是低级烷氧基,低级烷基或卤素; p是0或1; n是0,1或2; 如果n是2,则R 4可以相同或不同; m是0,1或2; 如果m是2,则R 1可以相同或不同; o是0,1,2或3,如果o是2或3,则R 2可以相同或不同; 或其药学活性酸加成盐。 式(I)化合物是β-淀粉样蛋白的调节剂,因此它们可用于治疗或预防与β-淀粉状蛋白在脑中沉积相关的疾病,特别是阿尔茨海默氏病和其他疾病,如脑 具有淀粉样变性的遗传性脑出血,荷兰型(HCHWA-D),多发性梗塞型痴呆,拳击员痴呆和唐氏综合症。
    • 9. 发明申请
    • GAMMA SECRETASE MODULATERS
    • GAMMA秘密调制解调器
    • WO2011092272A1
    • 2011-08-04
    • PCT/EP2011/051184
    • 2011-01-28
    • F. HOFFMANN-LA ROCHE AGBAUMANN, KarlheinzGOETSCHI, ErwinGREEN, LukeJOLIDON, SyneseKNUST, HennerLIMBERG, AnjaLUEBBERS, ThomasTHOMAS, Andrew
    • BAUMANN, KarlheinzGOETSCHI, ErwinGREEN, LukeJOLIDON, SyneseKNUST, HennerLIMBERG, AnjaLUEBBERS, ThomasTHOMAS, Andrew
    • C07D471/04C07D487/04C07D498/04A61K31/4196A61P25/00
    • C07D471/04C07D487/04C07D498/04
    • The invention relates to compounds of formula ( I ) wherein R 1 /R 1' are independently from each other hydrogen, halogen, lower alkoxy or cyano; R 2 is lower alkyl, halogen, lower alkoxy, lower alkyl substituted by halogen, lower alkoxy substituted by halogen, lower alkyl substituted by OR, =0, -C(O)O-lower alkyl, -C(O)NH-lower alkyl, cyano, CH 2 -O-lower alkyl, cycloalkyl, NRR'or is -O-(CH 2 ) o -phenyl optionally substituted by halogen, or is -(CH 2 ) o -phenyl optionally substituted by one, two or three substituents, selected from halogen, -(CH 2 ) o -cyano, lower alkyl, lower alkyl substituted by halogen, lower alkyl substituted by hydroxy, C(O)H, -CH 2 -NH 2 -, -CH 2 -NH-C(O)O-lower alkyl, -CH 2 -NH-C(O)-lower alkyl, -CH 2 -NH-lower alkyl, -CH 2 -NH-S(O) 2 -lower alkyl, lower alkoxy or by lower alkoxy substituted by halogen, or is -(CH 2 ) o -cycloalkyl, or is -(CH 2 ) o -heterocycloalkyl which is optionally substituted by halogen, CF 3 , lower alkyl, -CH 2 CN, -C(O)-lower alkyl, -C(O)O-lower alkyl or S(O) 2 -lower alkyl, or is heteroaryl selected from the group consisting of furanyl, pyrazinyl, pyridinyl, benzooxazolyl or benzoimidazolyl which are optionally substituted by lower alkyl, or is 4-methyl-3,4-dihydro-2H-benzo[l,4]oxazine R and R' are independently from each other hydrogen or lower alkyl, and o is 0 or 1; R 3 may occur once or twice and is lower alkyl; A is Formula a), b), c), d), e), f), h), i), j) and Formula k); R 2' is hydrogen, lower alkyl, lower alkyl substituted by halogen, C(O)-lower alkyl, S(O) 2 -lower alkyl or phenyl optionally substituted by halogen; hetaryl is a 5 or 6 membered N, S or O-containing heteroaryl group; n is O, 1, 2 or 3; if n is 2 or 3, R 2 may be the same or not; or to pharmaceutically active acid addition salts thereof. The present compounds of formula ( I ) are modulators for amyloid beta and thus, they may be useful for the treatment or prevention of a disease associated with the deposition of β-amyloid in the brain, in particular Alzheimer's disease, and other diseases such as cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi- infarct dementia, dementia pugilistica and Down syndrome.
    • 本发明涉及其中R 1 / R 1'彼此独立地为氢,卤素,低级烷氧基或氰基的式(I)化合物; R2是低级烷基,卤素,低级烷氧基,被卤素取代的低级烷基,被卤素取代的低级烷氧基,被OR取代的低级烷基,= 0,-C(O)O-低级烷基,-C(O) ,氰基,CH 2 -O-低级烷基,环烷基,NRR'或是任选被卤素取代的-O-(CH 2)o - 苯基,或是被选定的被一个,两个或三个取代基任选取代的 - (CH 2) 卤代低级烷基,被卤素取代的低级烷基,被羟基取代的低级烷基,C(O)H,-CH 2 -NH 2 - , - CH 2 -NH-C(O)O-低级 烷基,-CH 2 -NH-C(O) - 低级烷基,-CH 2 -NH-低级烷基,-CH 2 -NH-S(O)2 - 低级烷基,低级烷氧基或被卤素取代的低级烷氧基, (CH 2)o - 环烷基,或者是 - (CH 2)o - 杂环烷基,其任选被卤素,CF 3,低级烷基,-CH 2 CN,-C(O) - 低级烷基,-C(O)O-低级烷基或 S(O)2-低级烷基,或者是选自呋喃基,吡嗪基,吡啶基,苯并恶唑基或苯并咪唑基的杂芳基。 或是4-甲基-3,4-二氢-2H-苯并[1,4]恶嗪R和R'彼此独立地为氢或低级烷基,o为0或1; R3可以发生一次或两次,并且是低级烷基; A是公式a),b),c),d),e),f),h),i),j)和公式k); R 2'是氢,低级烷基,被卤素取代的低级烷基,C(O) - 低级烷基,任选被卤素取代的S(O)2 - 低级烷基或苯基) 杂芳基是5或6元N,S或O的杂芳基; n是0,1,2或3; 如果n为2或3,则R2可以相同或不相同; 或其药物活性的酸加成盐。 本发明的式(I)化合物是淀粉样蛋白β的调节剂,因此它们可用于治疗或预防与脑中β-淀粉样蛋白沉积相关的疾病,特别是阿尔茨海默病,以及其他疾病,例如 脑淀粉样血管病,遗传性脑出血伴淀粉样变性,荷兰型(HCHWA-D),多发梗死性痴呆,痴呆和唐氏综合征。